Literature DB >> 12351995

Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms.

Valerie Askanas1, W King Engel.   

Abstract

PURPOSE OF REVIEW: Sporadic inclusion-body myositis (s-IBM) and hereditary inclusion body myopathies are progressive muscle diseases that lead to severe disability. We discuss recent advances in illuminating their pathogenic mechanism(s). RECENT
FINDINGS: We emphasize how different etiologies might lead to the strikingly similar pathology and possibly similar pathogenic cascade. Our basic hypothesis is that over-expression of amyloid-beta precursor protein within aging muscle fibers is an early upstream event causing the subsequent pathogenic cascade. On the basis of our research, several processes seem to be important in relation to the still speculative pathogenesis: (a) increased transcription and accumulation of amyloid-beta precursor protein, and accumulation of its proteolytic fragment Abeta; (b) accumulations of phosphorylated tau and other Alzheimer-related proteins; (c) accumulation of cholesterol and low-density lipoprotein receptors, the cholesterol accumulation possibly due to its abnormal trafficking; (d) oxidative stress; and (e) a milieu of muscle cellular aging in which these changes occur. We discuss unfolded and/or misfolded proteins as a possible mechanism in formation of the inclusion bodies and their consequences. The remarkable pathologic similarities between s-IBM muscle and Alzheimer disease brain are discussed.
SUMMARY: Unfolding knowledge of the various pathogenetic aspects of the s-IBMs and hereditary inclusion body myopathies may lead to new therapeutic avenues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351995     DOI: 10.1097/00019052-200210000-00002

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  22 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes.

Authors:  Marinos C Dalakas
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.

Authors:  Anna Nogalska; Carla D'Agostino; W King Engel; Mafalda Cacciottolo; Shinichi Asada; Kazutoshi Mori; Valerie Askanas
Journal:  J Neuropathol Exp Neurol       Date:  2015-06       Impact factor: 3.685

Review 4.  ER stress in skeletal muscle remodeling and myopathies.

Authors:  Dil Afroze; Ashok Kumar
Journal:  FEBS J       Date:  2017-12-29       Impact factor: 5.542

Review 5.  P62/SQSTM1 at the interface of aging, autophagy, and disease.

Authors:  Alessandro Bitto; Chad A Lerner; Timothy Nacarelli; Elizabeth Crowe; Claudio Torres; Christian Sell
Journal:  Age (Dordr)       Date:  2014-02-21

6.  Increased expression and local accumulation of the prion protein, Alzheimer Aβ peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes.

Authors:  Claudine L Bitel; Yicheng Feng; Nizar Souayah; Peter H Frederikse
Journal:  BMC Physiol       Date:  2010-09-06

7.  Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease.

Authors:  Nina Raben; Victoria Hill; Lauren Shea; Shoichi Takikita; Rebecca Baum; Noboru Mizushima; Evelyn Ralston; Paul Plotz
Journal:  Hum Mol Genet       Date:  2008-09-09       Impact factor: 6.150

Review 8.  Mechanisms of muscle growth and atrophy in mammals and Drosophila.

Authors:  Rosanna Piccirillo; Fabio Demontis; Norbert Perrimon; Alfred L Goldberg
Journal:  Dev Dyn       Date:  2013-10-24       Impact factor: 3.780

9.  Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification.

Authors:  Alicia N Minniti; Daniela L Rebolledo; Paula M Grez; Ricardo Fadic; Rebeca Aldunate; Irene Volitakis; Robert A Cherny; Carlos Opazo; Colin Masters; Ashley I Bush; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2009-01-06       Impact factor: 14.195

10.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.